PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q2 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,039 | -19.8% | 13,107 | 0.0% | 0.00% | -50.0% |
Q2 2023 | $21,233 | -23.9% | 13,107 | 0.0% | 0.01% | -46.7% |
Q1 2023 | $27,918 | -59.3% | 13,107 | -29.2% | 0.02% | -55.9% |
Q4 2022 | $68,531 | +226.3% | 18,522 | -35.7% | 0.03% | +385.7% |
Q3 2022 | $21,000 | -12.5% | 28,821 | -5.3% | 0.01% | -30.0% |
Q2 2022 | $24,000 | -14.3% | 30,422 | 0.0% | 0.01% | -23.1% |
Q1 2022 | $28,000 | – | 30,422 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |